방사선 선량 관리 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Radiation Dose Management Market size is expected to reach USD 1455.26 Million in 2034 from USD 400.32 Million (2025) growing at a CAGR of 15.42% during 2026-2034.

The global radiation dose management market is growing steadily as healthcare providers focus on improving patient safety during medical imaging procedures. Radiation dose management systems help monitor, track, and optimize radiation exposure from imaging technologies such as CT scans, X-rays, and fluoroscopy. Increasing use of medical imaging for disease diagnosis is contributing to the expansion of this market.

A key driver of the market is the rising awareness about the potential health risks associated with excessive radiation exposure. Hospitals and diagnostic centers are implementing dose management software to ensure compliance with safety regulations and to maintain accurate records of patient radiation exposure. Additionally, growing regulatory requirements in many countries are encouraging healthcare facilities to adopt advanced monitoring systems.

In the future, the radiation dose management market is expected to expand as healthcare organizations continue to prioritize patient safety and quality care. Technological advancements in imaging equipment and data analytics will improve the ability to monitor and control radiation levels. The increasing adoption of digital healthcare systems and integrated hospital software will further support market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Services

• Software
• Services

By Modality

• Computed Tomography
• Radiography and Mammography
• Fluoroscopy and Interventional Imaging
• Nuclear Medicine Scan
• Others

By Application

• Oncology
• Cardiology
• Orthopedic
• Others

By End-user

• Hospitals
• Ambulatory Care Settings
• Research Organizations
• Others

COMPANIES PROFILED

• Landauer, AgfaGevaert Group, Sectra AB, Infinitt Healthcare Co Ltd, Bayer AG, PACSHealth, LLC, Koninklijke Philips NV, GE Healthcare, Thermo Fisher Scientific Inc, Medsquare SAS, Siemens, Fujifilm Holdings Corporation, Qaelum NV
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RADIATION DOSE MANAGEMENT MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RADIATION DOSE MANAGEMENT MARKET: BY MODALITY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Modality
• 5.2. Computed Tomography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Radiography and Mammography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Fluoroscopy and Interventional Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nuclear Medicine Scan Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RADIATION DOSE MANAGEMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Orthopedic Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RADIATION DOSE MANAGEMENT MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL RADIATION DOSE MANAGEMENT MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product And Services
  • 8.2.2 By Modality
  • 8.2.3 By Application
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product And Services
  • 8.3.2 By Modality
  • 8.3.3 By Application
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product And Services
  • 8.4.2 By Modality
  • 8.4.3 By Application
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product And Services
  • 8.5.2 By Modality
  • 8.5.3 By Application
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product And Services
  • 8.6.2 By Modality
  • 8.6.3 By Application
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL RADIATION DOSE MANAGEMENT INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Landauer
  • 10.2.2 Agfa-Gevaert Group
  • 10.2.3 Sectra AB
  • 10.2.4 Infinitt Healthcare Co. Ltd
  • 10.2.5 Bayer AG
  • 10.2.6 PACSHealth, LLC
  • 10.2.7 Koninklijke Philips N.V
  • 10.2.8 GE Healthcare
  • 10.2.9 Thermo Fisher Scientific Inc
  • 10.2.10 Medsquare SAS
  • 10.2.11 Siemens
  • 10.2.12 Fujifilm Holdings Corporation
  • 10.2.13 Qaelum NV